Does Breast Cancer Treatment Lead to Weight Gain?

When a breast cancer diagnosis arrives, patients often have a flood of questions about the why, how, and next steps. One area frequently overlooked is the potential for weight gain during and after treatment.

Multiple studies show that weight gain is common among breast cancer survivors, and that excess weight can elevate the risk of recurrence and impact overall prognosis. This article explains the mechanisms behind this phenomenon and offers actionable strategies.

Researchers consider weight gain in breast cancer patients to be multifactorial. For instance, chemotherapy can alter taste and smell, leading to changes in appetite and food choices. Fatigue and the side effects of treatment often reduce motivation and capacity for regular physical activity, while certain therapies may lower metabolic rate.

Some treatment regimens also induce premature menopause, a period that is associated with a modest increase in body weight.

How much weight do women typically gain?

A 2021 prospective study reported an average gain of 1.2 kg (2.64 lb) during early‑stage breast cancer treatment. Subsequent research in 2022 followed survivors over three years and found incremental increases: 0.79 kg (1.74 lb) at one year and 1.23 kg (2.71 lb) at three years.

Even modest weight gain can worsen breast cancer outcomes, raise the likelihood of type 2 diabetes, cardiovascular disease, and increase breast‑cancer‑related mortality, according to the same studies.

In 2023, investigators identified distinct biological differences in breast cancer cells between women with a BMI over 30 and those with lower BMIs. The higher‑BMI group’s cells exhibited greater inflammation and unique mutational profiles, hinting at potential pathways for targeted therapies.

While research is ongoing, the evidence underscores the importance of proactive weight management. Discuss with your oncologist how lifestyle modifications—balanced nutrition, portion control, and a structured exercise plan—can be integrated safely into your treatment regimen.

Obesity is a well‑established risk factor for several cancers, including breast, endometrial, and ovarian cancers. Excess adipose tissue produces elevated estrogen, fueling hormone‑receptor‑positive breast cancers. Additionally, higher insulin levels associated with obesity have been linked to tumor growth.

Other contributors to breast‑cancer risk include nulliparity, lack of breastfeeding, and certain hormone‑replacement therapies. If you are considering menopausal hormone therapy, weigh the benefits against the potential increased cancer risk with your healthcare provider.

Not every patient will experience weight gain, but many do. If you’re concerned about how additional weight might affect your physical and mental well‑being, reach out to your cancer care team. They can help tailor strategies that align with your treatment plan and minimize unwanted weight gain.